Patterns of survival in mantle cell lymphoma

Annals of Oncology

Volumn 6, Issue 3, 1995, Pages 257-262

  Zucca, E ^a   Roggero, E ^a   Pinotti, G ^b   Pedrinis, E ^c   Cappella, C ^d   Venco, A ^b   Cavalli, F ^b  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b Ospedale Multizonale Varese   (Italy)

^c INSTITUTE OF PATHOLOGY   (Switzerland)

^d NONE   (Italy)

Author keywords

Anthracycline; Chemotheraphy; Mantle cell lymphoma; Non Hodgkin's lymphoma; Prognostic factors

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0028920013     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a059155     Document Type: Article

References (28)

1. Banks P.M. Chan J. Cleary M.L. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic and molecular data Am J Surg Pathol 16 1992 637 640
2. Harris N. Jaffe E.S. Stein H. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392
3. Zucca E. Stein H. Coiffier B. European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL) Ann Oncol 5 1994 507 511
4. Weisenburger D.D. Sanger W.G. Armitage J.O. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings Blood 69 1987 1617 1621
5. Erikson J. Finan J. Tsujimoto Y. The chromosome 14 breakpoint in neoplastic B-cell with the t(11;14) translocation involves the immunoglobulin heavy chain locus Proc Natl Acad Sci USA 81 1984 4144 4148
6. Medeiros L.J. Van Krieken J.H. Jaffe E.S. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation Blood 76 1990 2086 2090
7. Williams M.E. Swerdlow S.H. Rosenberg C.L. Chromosome 11 translocation breakpoint at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma Leukemia 7 1993 241 245
8. De Boer C.J. Loyson S. Kluin P.M. Multiple breakpoint within the BCL-1 locus in B-cell lymphoma: Rearrangements of the cyclin Dl gene Cancer Res 53 1993 4148 4152
9. Rosenberg C.L. Motokura T. Kronenberg H.M. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors Oncogene 8 2 1993 519 521
10. Rimokh R. Berger F. Delsol G. Rearrangement and over-expression of the BCL-1/PRAD1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias Blood 81 1993 3063 3067
11. Shivdasani R.A. Hess J.L. Skarin A.T. Intermediate lymphocytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin’s lymphoma J Clin Oncol 11 1993 802 811
12. Shipp M.A. (The International Non-Hodgkin’s Lymphoma Prognostic Factors Project). A predictive model for aggressive non-Hodgkin’s lymphoma N Engl J Med 329 1993 987 994
13. Kaplan E.L. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. Peto R. Armitage P. Breslow N.E. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II Analysis and examples Br J Cancer 35 1977 1 39
15. Cox D.R. Regression models and life tables J R Stat Soc B 34 1972 187 220
16. Siegel S. Nonparametric Statistics 1956 McGraw Hill Publishers New York
17. Weisenberger D.D. Nathwani B.N. Diamond L.W. Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases Cancer 48 1981 1415 1425
18. Swerdlow S.H. Habeshaw J.A. Murray L.J. Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse Am J Pathol 113 1983 181 197
19. Narang S. Wolf B.C. Neiman R.S. Malignant lymphoma presenting with prominent splenomegaly. A clinicopathologic study with special reference to intermediate cell lymphoma Cancer 55 1985 1948 1957
20. Carbone A. Poletti A. Manconi R. Intermediate lymphocytic lymphoma encompassing diffuse and mantle zone pattern variants. A distinct entity among low-grade lymphomas? Eur J Cancer Clin Oncol 25 1989 113 121
21. Bookman M.A. Lardelli P. Jaffe E.S. Lymphocytic lymphoma of intermediate differentiation: Morphologic, immunophenotypic, and prognostic factors J Natl Cancer Inst 82 1990 742 748
22. Zucca E. Fontana S. Roggero E. Treatment and prognosis of centrocytic (mantle cell) lymphoma: A retrospective analysis of 26 patients treated in one institution Leukemia and Lymphoma 13 1994 105 110
23. Horning S.J. Diffuse small cell lymphomas Magrath I.T. The Non-Hodgkin’s Lymphomas 1990 Williams & Wilkins Baltimore 309 316
24. Longo D.L. Young R.C. Hubbard S.M. Prolonged initial remission in patients with nodular mixed lymphoma Ann Intern Med 100 1984 651 656
25. McLaughlin P. Fuller L.M. Velasquez W.S. Stage IQ follicular lymphoma: Durable remissions with a combined chemotherapy-radiotherapy regimen J Clin Oncol 5 1987 838 839
26. Meusers P. Engelhard M. Bartels H. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis Hematol Oncol 7 1989 365 380
27. Leith C.P. Spier C.M. Grogan T.M. Diffuse small cleavedcell lymphoma: A heterogeneous disease with distinct immunobiologic subsets J Clin Oncol 10 1992 1259 1265
28. Vose V.M. Weisenburger D.D. Anderson J.R. Mantle cell lymphoma (MCL) has a poorer prognosis than follicular non-Hodgkin’s lymphoma however, high dose therapy and autologous stem cell transplantation may overcome treatment resistance in MCL Blood 82 1993 135a